semaglutide and mounjaro Ozempic® (semaglutide) Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Semaglutide vs. Tirzepatide: How Weight-Loss
Description
Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind phase 3 trial
The BMJ , 392 , e085304
This reflects a broader access problem that disproportionately affects lupus patients because their indication for these medications (managing corticosteroid-induced weight gain and reducing cardiovascular risk in an autoimmune condition) does not fit neatly into approved indication categories
Supplementing with magnesium can help to address this underlying cause and reduce (and prevent) headaches, muscle cramps, and pain
The physician needs to obtain approval from a so-called institutional review board to ensure the patient is properly informed about the risks of taking an experimental treatment
